A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Prostaglandin E2, Serum/Plasma
Test Code91901
CPT Codes
84150
Preferred Specimen
3 mL frozen serum collected in a red-top tube (no gel) or 3 mL frozen plasma collected in an EDTA (lavender-top) tube
Minimum Volume
1 mL
Transport Temperature
Frozen
Specimen Stability
Room temperature: Unstable
Refrigerated: 24 hours
Frozen: 90 days
Refrigerated: 24 hours
Frozen: 90 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Received room temperature • Received refrigerated • Serum Separator Tube (SST®)
Methodology
Enzyme Linked Immunosorbent Assay (ELISA) • Extraction
FDA Status
The performance characteristics of this test were determined by Pan Laboratories, Irvine, CA. It has not been cleared or approved by the U.S. Food and Drug Administration.
Setup Schedule
A.M. Sets up 1 day a week.
Clinical Significance
Prostaglandins are synthesized from arachidonic acid by cyclooxygenase (COX)-1 or -2, which converts the acid into PGH2. This is further processed by cytosolic or microsomal prostaglandin synthesis to become prostaglandin E2. PG E2 is produced in many tissues and the level is increased during inflammation, arthritis, fever, endometriosis, tissue injury, pheochromocytoma, VIP producing tumors and variety of cancers with amine peptide productions. Prostaglandin E2 production and circulating levels are reduced by aspiring and indomethacin treatment.